Predicting GLP-1 Discontinuation From Pharmacy Claims
Published: | Updated:
|Articles|February 1, 2001
Supplements and Featured Publications
- Emerging Strategies in the Treatment of Gastroesophageal Reflux Disease
- Volume 7
- Issue 1 Suppl
The Impact of Nonsteroidal Anti-Inflammatory Drug-Induces Gastropathy
Author(s)James M. Scheiman, MD
Advertisement
Articles in this issue
over 25 years ago
Participating Facultyover 25 years ago
Introductionover 25 years ago
How Far to Go? Screening and Surveillance in Barrett's Esophagusover 25 years ago
Debating the Role of Helicobacter pylori Infectionover 25 years ago
Continuing Medical Education Quizover 25 years ago
Selected AbstractsAdvertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
Trump Childhood Vaccine Order: What It Means for Parents and Payers
2
FDA Proposes GRAS Rule, Advances Ultra-Processed Food Definition
3
Orelabrutinib Cuts Progression Risk 68% in Frontline CLL/SLL
4
Extreme Heat May Increase Microplastic Exposure, Related Health Concerns: Eva R. Parker, MD
5